Schedule 13G ownership disclosure

Solid Biosciences Inc

Common Stock, par value $0.001 per share · CUSIP: 83422E204

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Vestal Point Capital, LP

    Shares: 1,753,558.00 · Class: 2.3%

  • Ryan Wilder

    Shares: 1,753,558.00 · Class: 2.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-002394
Form type
SCHEDULE 13G/A
Filer
Solid Biosciences Inc.
CIK
CIK 1707502
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub